Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relationship Between Histopathological Features, Mutation Status, 18F-FDG PET/CT Radiomic Imaging Parameters as Well as Clinical Outcome in Patients With Treatment-naïve Non-small Cell Lung Cancer

NCT04276025 is registered in ClinicalTrials.gov with Klinikum Bayreuth GmbH as lead sponsor.

NCT NCT04276025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04276025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relationship Between Histopathological Features, Mutation Status, 18F-FDG PET/CT Radiomic Imaging Parameters as Well as Clinical Outcome in Patients With Treatment-naïve Non-small Cell Lung Cancer
Lead sponsor
Klinikum Bayreuth GmbH
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
January 31, 2020
Enrollment
2,000 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc